Skip to Content
Cancer Diagnosis Program
Contact NExT
Show menu
Search this site
Last Updated: 05/24/24

Diagnostics Evaluation Branch (DEB)

The Diagnostics Evaluation Branch (DEB) facilitates the development of markers and validation of innovative in vitro diagnostics to improve clinical outcomes for cancer patients.

  • Stimulating and supporting research to use in vitro diagnostics as prognostic markers to improve tumor classification and predictive markers to improve response to therapy.
  • Collaborating with other researchers and Government agencies to analytically and clinically validate in vitro diagnostics and their clinical utility.

DEB Staff

Name Position Primary Email Phone
Magdalena Thurin, Ph.D. Acting Branch Chief (240) 276-5973
Nina Lukinova, Ph.D. Program Director (240) 276-5309
Sumana Dey, Ph.D. Program Director (240) 276-5748
Sanita Bharti, Ph.D. Program Director